RACHEL JOAO: Open Payments
NPI 1548808074 · AVON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 55 payments from 14 companies in 2025. Trend: 2023 $632 · 2024 $670 · 2025 $1,254
Food & beverage: $1,235Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $366 |
| Ardelyx, Inc. | 7 | $245 |
| Janssen Biotech, Inc. | 4 | $190 |
| PFIZER INC. | 6 | $105 |
| QOL Medical, LLC | 5 | $105 |
| Novo Nordisk Inc | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $19 |
Products named: IBSRELA, TREMFYA, SKYRIZI, LINZESS, Sucraid, VELSIPITY, RINVOQ, Wegovy.
Industry payments across CT — which companies pay providers there.
